| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | ceranib-2 | CTRPv2 | pan-cancer | AAC | -0.067 | 0.04 |
| mRNA | NVP-BSK805 | CTRPv2 | pan-cancer | AAC | -0.07 | 0.04 |
| mRNA | COL-3 | CTRPv2 | pan-cancer | AAC | -0.078 | 0.04 |
| mRNA | L-685458 | CTRPv2 | pan-cancer | AAC | -0.075 | 0.05 |
| mRNA | AZ-3146 | CTRPv2 | pan-cancer | AAC | -0.07 | 0.05 |
| mRNA | Methotrexate | CTRPv2 | pan-cancer | AAC | -0.074 | 0.05 |
| mRNA | PD 153035 | CTRPv2 | pan-cancer | AAC | -0.085 | 0.05 |
| mRNA | CAY10618 | CTRPv2 | pan-cancer | AAC | -0.069 | 0.05 |
| mRNA | selumetinib:GDC-0941 (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.071 | 0.05 |
| mRNA | PHA-793887 | CTRPv2 | pan-cancer | AAC | -0.061 | 0.05 |